 alpha-Fetoproteins
"alpha-Fetoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.
| Descriptor ID |
D000509
|
| MeSH Number(s) |
D12.776.124.790.106.092 D12.776.320.525.500 D12.776.377.228.500 D12.776.377.715.085.092 D23.101.140.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "alpha-Fetoproteins".
Below are MeSH descriptors whose meaning is more specific than "alpha-Fetoproteins".
This graph shows the total number of publications written about "alpha-Fetoproteins" by people in this website by year, and whether "alpha-Fetoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 | | 1997 | 1 | 1 | 2 | | 2000 | 0 | 1 | 1 | | 2001 | 1 | 0 | 1 | | 2004 | 0 | 2 | 2 | | 2009 | 1 | 1 | 2 | | 2010 | 0 | 1 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 2 | 1 | 3 | | 2013 | 0 | 2 | 2 | | 2015 | 1 | 1 | 2 | | 2016 | 1 | 0 | 1 | | 2019 | 1 | 1 | 2 | | 2020 | 1 | 1 | 2 | | 2021 | 0 | 1 | 1 | | 2022 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 | | 2024 | 2 | 0 | 2 | | 2025 | 2 | 1 | 3 | | 2026 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "alpha-Fetoproteins" by people in Profiles.
-
Rich BS, Fishbein JS, Purcell LN, Murphy JT, Castle SL, Ghanbari N, Zohrabian A, Lautz TB, Kacey W, Post G, Thangarajah H, West E, Roach JP, Corkum KS, Perry T, Piché N, Roy M, Stafman LL, Dixon SM, Glithero KJ, Pittman ME, Çeliker MY, Grant CN, Sharf T, Tracy ET, Wachsmuth LP, Rustad A, Newman EA, Williams K, Wunker CM, Glick RD, Dasgupta R, Wilson S, Vore E, Cromeens BP, Turk F, Shaffiey SA, Alkhoury F, Goyal J, Brown EG, Seemann NM, Wilson CA, Davidson J, Polites SF, Parrish MT, Cameron DB, Stetson A, Gold RM, Aldrink JH, Mansfield SA, Srivatsa S, Christison-Lagay E, Rehman SU, Fialkowski EA, Selesner L, Larsen A, Le HD, Tracy SA, Ahmed T, Dimmer A, Malek MM, Campwala I, Colangelo A, Rothstein DH, Nchinda NN, Mattei P, Jain S, Hwang R, Craig BT, Lal DR, Abrebese E, Rhee DS, Chidiac C, Peters M, Boehmer C, Billmire DF. Immature teratoma of the ovary in children and adolescents: A multi-institutional study of characteristics and management. Gynecol Oncol. 2026 Aug; 211:115-124.
-
Kawashima J, Akabane M, Khalil M, Woldesenbet S, Endo Y, Sahara K, Ruzzenente A, Ratti F, Marques HP, Oliveira S, Balaia J, Cauchy F, Lam V, Poultsides GA, Kitago M, Popescu I, Martel G, Gleisner A, Hugh T, Weiss M, Aucejo F, Aldrighetti L, Endo I, Pawlik TM. Model of End-Stage Liver Disease-alpha-fetoprotein-tumor burden (MELD-AFP-TBS) score to stratify prognosis after liver resection for hepatocellular carcinoma. Surgery. 2025 Jul; 183:109388.
-
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Oliveira S, Balaia J, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP Dynamics. Ann Surg Oncol. 2025 Aug; 32(8):5648-5656.
-
Altaf A, Khalil M, Akabane M, Rashid Z, Kawashima J, Zindani S, Ruzzenente A, Ratti F, Marques H, Cauchy F, Lam V, Poultsides G, Aucejo F, Kitago M, Popescu I, Martel G, Gleisner A, Bauer TW, Hugh T, Bhimani N, Shen F, Endo I, Pawlik TM. Up-front resection for hepatocellular carcinoma: Assessing futility in the preoperative setting. Eur J Surg Oncol. 2025 05; 51(5):109594.
-
Rolfes PS, Sundaram SS, Sokol RJ, Taylor SA. Establishing Neonate-Specific Prognostic Markers in Acute Liver Failure: Admission Alpha Fetoprotein and Novel Neonatal Acute Liver Failure Scores Predict Patient Outcomes. J Pediatr. 2024 09; 272:114080.
-
Endo Y, Tsilimigras DI, Munir MM, Woldesenbet S, Yang J, Guglielmi A, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Popescu I, Alexandrescu S, Martel G, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Prognostic significance of postoperative complications for patients with hepatocellular carcinoma relative to alpha-feto protein and tumor burden score. HPB (Oxford). 2024 08; 26(8):998-1006.
-
Resende V, Tsilimigras DI, Endo Y, Guglielmi A, Ratti F, Aldrighetti L, Marques HP, Soubrane O, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Gleisner A, Martel G, Hugh T, Endo I, Shen F, Pawlik TM. Machine-Based Learning Hierarchical Cluster Analysis: Sex-Based Differences in Prognosis Following Resection of Hepatocellular Carcinoma. World J Surg. 2023 12; 47(12):3319-3327.
-
Seyoum EA, Anderson LR. The Case of the Silent Abdominal Mass and Elevated a-Fetoprotein Level in an Infant. Pediatr Rev. 2022 11 01; 43(11):651-654.
-
Myklebust MP, Thor A, Rosenlund B, Gjengstø P, Karlsdottir Á, Brydøy M, Bercea BS, Olsen C, Johnson I, Berg MI, Langberg CW, Andreassen KE, Kjellman A, Haugnes HS, Dahl O. Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study. Sci Rep. 2021 08 02; 11(1):15582.
-
Gomaa SH, Abaza MM, Elattar HA, Amin GA, Elshahawy DM. Soluble cluster of differentiation 26/soluble dipeptidyl peptidase-4 and glypican-3 are promising serum biomarkers for the early detection of Hepatitis C virus related hepatocellular carcinoma in Egyptians. Arab J Gastroenterol. 2020 Dec; 21(4):224-232.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|